These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12517040)

  • 1. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
    Tsai WC; Li YH; Chao TH; Chen JH
    J Formos Med Assoc; 2002 Oct; 101(10):681-4. PubMed ID: 12517040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S
    J Am Coll Cardiol; 2001 Mar; 37(3):775-9. PubMed ID: 11693751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis.
    Bui MN; Sack MN; Moutsatsos G; Lu DY; Katz P; McCown R; Breall JA; Rackley CE
    Am Heart J; 1996 Apr; 131(4):663-7. PubMed ID: 8721636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.
    Anselmi M; Garbin U; Agostoni P; Fusaro M; Pasini AF; Nava C; Keta D; Turri M; Zardini P; Vassanelli C; Lo Cascio V; Cominacini L
    Atherosclerosis; 2006 Mar; 185(1):114-20. PubMed ID: 15998517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
    Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction.
    Kayo S; Ohsawa M; Ehara S; Naruko T; Ikura Y; Hai E; Yoshimi N; Shirai N; Tsukamoto Y; Itabe H; Higuchi K; Arakawa T; Ueda M
    Am Heart J; 2004 Nov; 148(5):818-25. PubMed ID: 15523312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes.
    Emekli-Alturfan E; Basar I; Alturfan AA; Ayan F; Koldas L; Balci H; Emekli N
    Pathophysiol Haemost Thromb; 2007; 36(6):290-7. PubMed ID: 20224254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex link between oxidised low-density lipoprotein and unstable angina.
    Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidation ratio of LDL: a predictor for coronary artery disease.
    Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
    Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia.
    Hulthe J; Wikstrand J; Lidell A; Wendelhag I; Hansson GK; Wiklund O
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1203-11. PubMed ID: 9714126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia.
    Paiker JE; Raal FJ; von Arb M
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prooxidant-antioxidant balance and antioxidized LDL antibody level values and cardiac function in patients with coronary artery disease.
    Rahsepar AA; Mirzaee A; Moodi F; Moohebati M; Tavallaie S; Eshraghi A; Alavi MS; Khorashadizadeh F; Pourghadamyari H; Paydar R; Amini M; Khojasteh R; Mousavi S; Sahebi M; Ghayour-Mobarhan M; Ferns GA
    Cardiology; 2012; 122(4):203-9. PubMed ID: 22854352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Morooka S
    J Am Coll Cardiol; 2001 Jun; 37(7):1871-6. PubMed ID: 11401125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.